COMMUNIQUÉS West-GlobeNewswire
-
Virios Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
09/05/2024 - 13:45 -
Mounting Evidence that use of the Mental Health Collaborative Care Model is Associated with Reductions in Total Healthcare Costs
09/05/2024 - 13:48 -
NEXGEL to Report First Quarter 2024 Financial Results on May 13th
09/05/2024 - 14:00 -
ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives.
09/05/2024 - 14:00 -
AEON Biopharma Provides Update on Development Pipeline
09/05/2024 - 14:00 -
Intercept Announces New PBC Data Analyses to be Presented at Digestive Disease Week® 2024 Conference
09/05/2024 - 14:00 -
PDS Biotech to Participate in Upcoming May 2024 Investor Conferences
09/05/2024 - 14:00 -
Fulcrum Therapeutics to Participate in Upcoming May Conferences
09/05/2024 - 14:00 -
NewAmsterdam Pharma Provides Corporate Update and Reports First Quarter Financial Results
09/05/2024 - 14:00 -
RAPT Therapeutics Reports First Quarter 2024 Financial Results
09/05/2024 - 14:00 -
ACELYRIN, INC. Announces Leadership Transition
09/05/2024 - 14:00 -
Bionano Announces Series of Major Advancements to its Suite of Computational Tools for Comprehensive Cancer Analysis
09/05/2024 - 14:00 -
PMV Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Highlights
09/05/2024 - 14:00 -
Apnimed Announces Completion of Enrollment in Phase 3 LunAIRo Study of AD109, the Potential First Nighttime Oral Treatment for Obstructive Sleep Apnea
09/05/2024 - 14:00 -
Optimi Health Receives Export Permit from Health Canada to Ship MDMA To Tel Aviv University's Institute for Psychedelic Research
09/05/2024 - 14:00 -
VYNE Reports First Quarter 2024 Financial Results and Provides Business Update
09/05/2024 - 14:00 -
Volta Medical Featured in Latest Consensus Statement from Leading International Cardiac Electrophysiology Societies on Atrial Fibrillation Ablation
09/05/2024 - 14:00 -
Reviva to Present New Non-Clinical Pharmacology Data on Brilaroxazine at the ASPET 2024 Annual Meeting
09/05/2024 - 14:00 -
Cerevance Presents at IAPRD XXIX World Congress on Parkinson’s Disease and Related Disorders
09/05/2024 - 14:00
Pages